| Jon Warren Potter, DO | |
|
3940 Oakwood Hills Pkwy Ste 2, Eau Claire, WI 54701-8888 | |
| (715) 552-7303 | |
| (715) 552-7355 |
| Full Name | Jon Warren Potter |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 26 Years |
| Location | 3940 Oakwood Hills Pkwy Ste 2, Eau Claire, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093785180 | NPI | - | NPPES |
| 1055201131 | Other | MI | BLUE CROSS BLUE SHIELD |
| 4693501 | Medicaid | MI | |
| P00165661 | Other | MI | RAILROAD MEDICARE |
| 43546500 | Medicaid | WI |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sacred Heart Hospital | Eau claire, WI | Hospital |
| Oakleaf Surgical Hospital | Altoona, WI | Hospital |
| Marshfield Medical Center - Eau Claire | Eau claire, WI | Hospital |
| St Joseph's Hospital | Chippewa falls, WI | Hospital |
| Lakeview Medical Center Of Rice Lake | Rice lake, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Eau Claire Gi Associates Sc | 0244232502 | 4 |
| Mchs Hospitals Inc | 5698071173 | 1049 |
News Archive
A Phase I study, called RV262, recently began to evaluate a combination DNA prime/MVA vector boost vaccine regimen that was developed to protect against diverse subtypes of HIV-1 prevalent in North America, Europe, Africa and South America.
Researchers at Toronto Western Hospital's Canadian Concussion Centre have discovered the presence of chronic traumatic encephalopathy (CTE) in the brain of a deceased patient with no known history of traumatic brain injury or concussion, the first known case of its kind.
The Global Alliance for TB Drug Development (TB Alliance), a not-for-profit, product development partnership leading the development of new and affordable tuberculosis (TB) drugs, announced today a new grant and pledge of up to $40 million over the next five years from the United States Agency for International Development (USAID).
ARCA biopharma, Inc. a biopharmaceutical company developing genetically-targeted therapies for heart failure and other cardiovascular diseases, today announced that the European Patent Office has issued a patent on methods of treating heart failure patients with bucindolol based on genetic targeting.
Verathon®, maker of BladderScan® bladder volume instruments is pleased to announce that portable bladder volume ultrasound is now included in the new 2009 CDC guidelines for the Prevention of Catheter-Associated Urinary Tract Infections (CA-UTIs).
› Verified 3 days ago
| Entity Name | Marshfield Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952347981 PECOS PAC ID: 2264345206 Enrollment ID: O20031106000590 |
News Archive
A Phase I study, called RV262, recently began to evaluate a combination DNA prime/MVA vector boost vaccine regimen that was developed to protect against diverse subtypes of HIV-1 prevalent in North America, Europe, Africa and South America.
Researchers at Toronto Western Hospital's Canadian Concussion Centre have discovered the presence of chronic traumatic encephalopathy (CTE) in the brain of a deceased patient with no known history of traumatic brain injury or concussion, the first known case of its kind.
The Global Alliance for TB Drug Development (TB Alliance), a not-for-profit, product development partnership leading the development of new and affordable tuberculosis (TB) drugs, announced today a new grant and pledge of up to $40 million over the next five years from the United States Agency for International Development (USAID).
ARCA biopharma, Inc. a biopharmaceutical company developing genetically-targeted therapies for heart failure and other cardiovascular diseases, today announced that the European Patent Office has issued a patent on methods of treating heart failure patients with bucindolol based on genetic targeting.
Verathon®, maker of BladderScan® bladder volume instruments is pleased to announce that portable bladder volume ultrasound is now included in the new 2009 CDC guidelines for the Prevention of Catheter-Associated Urinary Tract Infections (CA-UTIs).
› Verified 3 days ago
| Entity Name | Eau Claire Gi Associates Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912078718 PECOS PAC ID: 0244232502 Enrollment ID: O20070215000543 |
News Archive
A Phase I study, called RV262, recently began to evaluate a combination DNA prime/MVA vector boost vaccine regimen that was developed to protect against diverse subtypes of HIV-1 prevalent in North America, Europe, Africa and South America.
Researchers at Toronto Western Hospital's Canadian Concussion Centre have discovered the presence of chronic traumatic encephalopathy (CTE) in the brain of a deceased patient with no known history of traumatic brain injury or concussion, the first known case of its kind.
The Global Alliance for TB Drug Development (TB Alliance), a not-for-profit, product development partnership leading the development of new and affordable tuberculosis (TB) drugs, announced today a new grant and pledge of up to $40 million over the next five years from the United States Agency for International Development (USAID).
ARCA biopharma, Inc. a biopharmaceutical company developing genetically-targeted therapies for heart failure and other cardiovascular diseases, today announced that the European Patent Office has issued a patent on methods of treating heart failure patients with bucindolol based on genetic targeting.
Verathon®, maker of BladderScan® bladder volume instruments is pleased to announce that portable bladder volume ultrasound is now included in the new 2009 CDC guidelines for the Prevention of Catheter-Associated Urinary Tract Infections (CA-UTIs).
› Verified 3 days ago
| Entity Name | Mchs Hospitals Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093221434 PECOS PAC ID: 5698071173 Enrollment ID: O20180208000096 |
News Archive
A Phase I study, called RV262, recently began to evaluate a combination DNA prime/MVA vector boost vaccine regimen that was developed to protect against diverse subtypes of HIV-1 prevalent in North America, Europe, Africa and South America.
Researchers at Toronto Western Hospital's Canadian Concussion Centre have discovered the presence of chronic traumatic encephalopathy (CTE) in the brain of a deceased patient with no known history of traumatic brain injury or concussion, the first known case of its kind.
The Global Alliance for TB Drug Development (TB Alliance), a not-for-profit, product development partnership leading the development of new and affordable tuberculosis (TB) drugs, announced today a new grant and pledge of up to $40 million over the next five years from the United States Agency for International Development (USAID).
ARCA biopharma, Inc. a biopharmaceutical company developing genetically-targeted therapies for heart failure and other cardiovascular diseases, today announced that the European Patent Office has issued a patent on methods of treating heart failure patients with bucindolol based on genetic targeting.
Verathon®, maker of BladderScan® bladder volume instruments is pleased to announce that portable bladder volume ultrasound is now included in the new 2009 CDC guidelines for the Prevention of Catheter-Associated Urinary Tract Infections (CA-UTIs).
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jon Warren Potter, DO 3940 Oakwood Hills Pkwy Ste 2, Eau Claire, WI 54701-8888 Ph: (715) 552-7303 | Jon Warren Potter, DO 3940 Oakwood Hills Pkwy Ste 2, Eau Claire, WI 54701-8888 Ph: (715) 552-7303 |
News Archive
A Phase I study, called RV262, recently began to evaluate a combination DNA prime/MVA vector boost vaccine regimen that was developed to protect against diverse subtypes of HIV-1 prevalent in North America, Europe, Africa and South America.
Researchers at Toronto Western Hospital's Canadian Concussion Centre have discovered the presence of chronic traumatic encephalopathy (CTE) in the brain of a deceased patient with no known history of traumatic brain injury or concussion, the first known case of its kind.
The Global Alliance for TB Drug Development (TB Alliance), a not-for-profit, product development partnership leading the development of new and affordable tuberculosis (TB) drugs, announced today a new grant and pledge of up to $40 million over the next five years from the United States Agency for International Development (USAID).
ARCA biopharma, Inc. a biopharmaceutical company developing genetically-targeted therapies for heart failure and other cardiovascular diseases, today announced that the European Patent Office has issued a patent on methods of treating heart failure patients with bucindolol based on genetic targeting.
Verathon®, maker of BladderScan® bladder volume instruments is pleased to announce that portable bladder volume ultrasound is now included in the new 2009 CDC guidelines for the Prevention of Catheter-Associated Urinary Tract Infections (CA-UTIs).
› Verified 3 days ago
Patrick D Macken, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 1425 Elderberry Ln, Eau Claire, WI 54701 Phone: 715-832-9801 | |
Sandeep K Basu, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1400 Bellinger St, Eau Claire, WI 54703 Phone: 715-838-5222 | |
Myles David Keroack, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2116 Craig Rd, Eau Claire, WI 54701 Phone: 715-858-4500 | |
Rebecca M Kallunki, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 1400 Bellinger St, Eau Claire, WI 54703 Phone: 715-838-5222 | |
Dr. Sameer Ahmad Batoo, MBBS Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1400 Bellinger St, Eau Claire, WI 54703 Phone: 715-838-5222 | |
Ali Zaied, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1400 Bellinger St, Eau Claire, WI 54703 Phone: 715-838-5222 | |
Allan J Sill, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 1400 Bellinger St, Eau Claire, WI 54703 Phone: 715-838-5222 |